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The hydrolysis of bovine whey protein concentrate (WPC), a-lactalbumin (a-La) and caseinomacropeptide
(CMP), by aqueous extracts of Cynara cardunculus, was optimized using response surface methodology.
Degree of hydrolysis (DH), angiotensin-converting enzyme (ACE)-inhibitory activity and antioxidant
activity were used as objective functions, and hydrolysis time and enzyme/substrate ratio as manipulated
parameters. The model was statistically appropriate to describe ACE-inhibitory activity of hydrolysates
fromWPC and a-La, but not from CMP. Maximum DHwas 18% and 9%, for WPC and a-La, respectively. 50%
ACE-inhibitionwas produced by105.4 (total fraction) and 25.6 mgmL1 (<3 kDa fraction) forWPC, and 47.6
(total fraction) and 22.5 mgmL1 (<3 kDa fraction) for a-La. Major peptides of fractions exhibiting ACE-
inhibition were sequenced. The antioxidant activities of WPC and a-La were 0.96 0.08 and
1.12 0.13 mmol trolox equivalent per mg hydrolysed protein, respectively.1. Introduction
Research encompassing bioactive peptides has significantly
increased during the past decade and extensive reviews have been
published (Korhonen & Pihlanto, 2006; Xu, 1998). Whilst not active
within the primary structure of their source proteins, peptides that
possess specific amino acid sequences known to exhibit biological
activity (Hartmann & Meisel, 2007) can be released through
enzyme-mediated hydrolysis.
As a result of increasing whey production worldwide by the
cheese-making industry, there is a growing interest towards novel
applications for whey. This is especially critical in smaller factories,
for which economically feasible alternative ways to reutilize whey
are required. Since whey contains more than half of the solids
present in the original milk e of which 20% is accounted for by
protein, value-adding to whey is possible via generation of bioac-
tive peptides for eventual use as dietary supplements. Much effort
has been put into production of ingredients that are helpful for: þ351 22 9825331.treatment (or prevention) of hypertension, which constitutes
a dominant health problem worldwide, and one of the highest risk
factors for eventual development of cardiovascular diseases.
Angiotensin-converting enzyme (ACE) has been implicated in
hypertension.
ACE occurs in many tissues and biological fluids and plays an
important physiological role in up-regulation of blood pressure
(López-Fandiño, Otte, & van Camp, 2006). Conventional antihyper-
tensive drugs thus act essentially as ACE inhibitors; however, they
cause several adverse secondary effects, so safer alternatives have
been sought. The capacity to inhibit ACE was found in many
peptides originating from food proteinsdincluding those in milk
and whey, as well as in egg, soy, maize (a-chain), fish and meat
(Hartmann & Meisel, 2007; Hong et al., 2008; Pihlanto & Korhonen,
2003).
On the other hand, oxidative metabolism is essential for survival
of cells, but it generates free radicals (and other reactive oxygen
species) as a side effect, which can cause oxidative damage. Anti-
oxidant activity has been found specifically in whey proteins; the
underlyingmechanism of actionmay be scavenging of such radicals






























































































































































































































































































































































































































































































































































































































































































































).The classical approach to produce bioactive peptides is enzy-
matic hydrolysis of whole food proteins; however, whey proteins in
aqueous solutions are not easily broken down by proteases (e.g.,
pepsin and trypsin)da realization that also explains their tendency
to cause allergies upon ingestion (Schmidt, Meijer, Slangen, & van
Beresteijn, 1995). Note that aspartic proteases are widely distrib-
uted in animals, plants and microorganisms; however, hydrolysis
has so far focused almost exclusively on aspartic proteases of
animal origin, so scientific curiosity has pushed experimentation
with similar enzymes but of plant origin. One such example
pertains to the flowers of the wild thistle, Cynara cardunculus,
which contain two aspartic proteases that can easily be extracted
with water, and act mainly on a-lactalbumin (a-La), either inwhole
whey or following concentration to whey protein concentrate
(WPC) (Barros & Malcata, 2002, 2004; Lamas, Barros, Balcão, &
Malcata, 2000). Although a-La is highly susceptible to those
enzymes, b-lactoglobulin (b-Lg) appears not to be hydrolysed to
a significant extent (Barros & Malcata, 2006).
Therefore, the major objectives of this work were to optimize the
enzymatic hydrolysis of threewhey-based substrates, viz.,WPC,a-La
and caseinomacropeptide (CMP), effected by an aqueous extract of
C. cardunculus, using degree of hydrolysis (DH), antioxidant power
and ACE-inhibitory activity as objective functions. Two easily
manipulated processing factors (i.e., reaction time and ratio of
enzyme/substrate, E/S) were selected for optimisation, following
a response surfacemethodology, which had already proven useful in
optimizing complex processes besides enzymatic catalysis (Herrero,
Martín-Álvarez, Señoráns, Cifuentes, & Ibañez, 2005; Lundstedt et al.,
1998; Mendiola et al., 2008). The specific peptides more directly
implicated in ACE-inhibitory activity were sequenced, so the origi-






































































































































































































































































































































































































































































































































































































































































































































































































































































L2. Materials and methods
2.1. Experimental design, modelling and optimisation
The effects of two processing factorsdE/S ratio and reaction
time, were studied upon DH; theywere also consideredwith regard
to the ACE-inhibitory and antioxidant activities of the corre-
sponding hydrolysates. Hydrolysis was brought about by
C. cardunculus on three whey-derived feedstocks, using a central
composite design with ten independent experiments: four exper-
iments were accounted for by two levels (1 and þ1) of the





); and the remaining two corresponded to centre
points (used as variance estimators, at nil coordinate). All experi-
ments were run in random order. This design permitted five
distinct levels to be tested: 1.6, 3.0, 6.5, 10.0 and 11.5% (v/v) for the
E/S ratio; and 0,1, 3.5, 6 and 7 h for the reaction time. The associated
matrix of experimental design and results is shown in Table 1.
The quadratic polynomial model proposed for each response
variable, Y, took the form:
Y ¼ b0 þ b1Rþ b2T þ b1;1R2 þ b2;2T2 þ b1;2RT þ 3 (1)
where: R denotes the E/S ratio and T the reaction time; b0 is the
vertical intercept; b1 and b2 are linear coefficients, b1,1 and b2,2 are
quadratic coefficients, and b1,2 is the interaction coefficient; and 3
denotes the experimental error. These parameters were estimated
by multiple linear regression using Statgraphics Plus, v. 5.1
(Statistical Graphics, Manugistics, MD, USA). The effect of each term
in the model, together with its statistical significance, for every
response variable was analysed via standardized Pareto charts. The
terms not significantly different from zero (P> 0.10) were excluded
from the final version of the model, which was then re-fitted to the
experimental data. Assessment of the goodness of fit used the
coefficient of determination (R2) and the residual standard devia-
tion (RSD). The contour plot of the response surfaces, as well as the
associated processing conditions that maximized each of the
response variables were obtained for the revised models.
2.2. Performance of enzymatic hydrolyses
Three substrates were experimentally testeddWPC 80 (Lac-
prodan, Arla Foods Ingredients, Denmark), a-La (Sigma, St. Louis,
MO, USA) and CMPpure (Danisco, Niebüll, Germany); they were
submitted to hydrolysis brought about by cardosins, previously
recovered as an aqueous extract of commercial thistle (Formulab,
Portugal), using the best pH and temperature conditions reported
elsewhere (Barros & Malcata, 2002).
Substrate solutions (40 g protein L1) were prepared by mixing
the protein powder with distilled water, followed by stirring for 1 h
at room temperature. The pH was adjusted to 5.2 with 0.1 M HCl.
The E/S ratio for each experiment was expressed on a protein basis,
knowing that the thistle extract possesses 15 g protein L1. This
mixture was incubated at 55 C for 7 h, and samples were taken by
0, 1, 3.5, 6 and 7 h (Table 1); quenching was by heating at 95 C for
15 min. The hydrolysates were centrifuged at 16,000 g for 15 min,
and the supernatants were frozen at 20 C (and kept likewise
until use). A portion of said supernatants was subjected to UF
through a hydrophilic 3 kDa cut-off membrane (Centripep, Beverly,
MA, USA), and the 3 kDa-permeates obtained were freeze-dried
and kept at 20 C until analysis was in order; these permeates
were reconstituted with distilled water prior to analytical charac-
terization. The same procedure was followed when the manipu-
lated parameters were at their optimum levels.
2.3. Assessment of degree of hydrolysis
DH was determined by measuring the increase in free amino
groups, using a picrylsulfonic acid solution (TNBS), according to
McKellar (1981). The percent DH was calculated as described by
Adler-Nissen (1979). All measurements were performed in
duplicate.
2.4. Assessment of angiotensin-converting
enzyme-inhibitory activity
The ACE-inhibitory activity was measured (in duplicate) using
the fluorimetric assay by Sentandreu and Toldrá (2006), with the
modification by Quirós, Contreras, Ramos, Amigo, and Recio (2009).
For this purpose, the protein content of the hydrolysates was
determined by Kjeldahl, and that of permeates by the bicinchoninic
acid assay (Pierce, Rockford, IL, USA)dusing bovine serum albumin
as standard. A non-linear fit to the experimental data was done to
calculate the 50% inhibitory concentration values (IC50), as specif-
ically described by Quirós et al. (2007).
2.5. Assessment of antioxidant activity
The Oxygen Radical Absorbance Capacity (ORAC) assay was
employed to evaluate the antioxidant potential of our hydroly-
sates, as indicated by Contreras, Hernández-Ledesma, Amigo,
Martín-Alvarez, and Recio (2011). All reaction mixtures were
prepared in duplicate, and at least three independent measures
were performed for each experiment. ORAC-fluorescein (FL) values
were expressed as mmol trolox equivalent per mg hydrolysed
protein, as proposed elsewhere (Hernández-Ledesma, Dávalos,
Bartolomé, & Amigo, 2005).2.6. Statistical analyses
All experimental results were analysed by one-way analysis of
variance (ANOVA), using Tukey’s post-hoc test at a significance
level of 5%; GraphPad Prism, v. 5.00 software was used for this
purpose (GraphPad Software, San Diego, CA, USA).
2.7. Identification of potentially bioactive peptides
The molecular masses of the components of the most active
fractions in the <3 kDa permeate, after resolution by reverse
phase-HPLC (RP-HPLC), were determined by mass spectrometry
(MS) as described by Quirós et al. (2009).
3. Results and discussion
3.1. Experimental design, modelling and optimisation
The values of the processing factors were selected to cover
a wide range of conditionsdas shown in Table 1, but bearing in
mind the practical constraints reported previously (Barros &
Malcata, 2002, 2004, 2006). In general, ACE-inhibitory activity
depends considerably on DH of the protein substrate(s), so it might
be argued that DH should have been included as a regressor rather
than as a response e in attempts to elucidate whether such a high
ACE-inhibition is just a result of extensive hydrolysis, or else due to
some intrinsic properties of the protein substrate(s) or specificity of
the enzyme(s). Besides going well beyond the goal of the present
study dealing with optimisation, and implying a far larger number
of experiments, the practical applicability of the results to be
generated in that case would be narrow e because R and I are
processing parameters that can be easily manipulated a priori,
unlike DH that would require feedback control and monitoring
before start-up in an industrial setting.
The results in Table 1 show a higher DH of WPC than a-La or
CMP. As mentioned above, a-La is more susceptible to cardosin-
mediated hydrolysis than b-Lg (the most abundant whey
protein); however, a-La hydrolysates will not necessarily account
for a higher amount of free amino groups (as measured by DH)
because bovine serum albumin (BSA) and CMP (among other minor
proteins) may also contribute significantly to DH.
WPC and a-La hydrolysates exhibited a higher antioxidant
power than CMP ones, but none of them possessed any significant
antioxidant activity (P> 0.05) when other milk protein hydroly-
sates were used as a reference: e.g., a pepsin-mediated hydrolysate
of k-casein (k-CN), with an ORAC value of 7.07 mmol trolox equiv-
alent per mg protein (López-Expósito, Quirós, Amigo, & Recio,
2007); or an a-La Corolase PP hydrolysate, with an ORAC value of
2.95 mmol trolox equivalent per mg protein (Hernández-Ledesma
et al., 2005).
Hydrolysates obtained from WPC and a-La showed significant
ACE-inhibitory activity (P< 0.001), unlike plainwhey or pure whey
proteins (IC50>1000 mgmL1, see Table 1). The low IC50 values
associated with the total hydrolysate fraction of WPC (i.e.,
72.0 3.7 mgmL1) and of a-La (i.e., 33.0 2.1 mgmL1) indicate
a notable ACE-inhibitory activity when compared with that of
hydrolysates from similar or related dairy proteins. For example,
Otte, Shalaby, Zakora, Pripp, and el-Shabrawy (2007) reported IC50
values of 382 and 477 mgmL1 for b-casein (CN) and CMP, respec-
tively, after hydrolysis by thermolysin; and the most efficient ACE
inhibitors, with IC50 values of 83 and 45 mgmL1, were obtained
from WPI and a-La, respectively, by those authors, but were worse
than those found here. Although several studies have conveyed
comparisons of performance of peptide mixtures versus captopril
(i.e., the standard ACE-inhibition drug), note that the core of our
study was optimisation of crude enzyme hydrolysates, rather than
characterisation of pure peptides ewhich would the only ones that
deserved testing against a pharmaceutical active principle.
In vitro ACE-inhibitory activity can be assessed by different
methods, yet most reports have used spectrophotometric, fluori-
metric and high performance liquid chromatography (HPLC) assays
(Hernández-Ledesma, Mar-Contreras, & Recio, 2010; Li, Liu, Shi, &
Le, 2005); in all the latter, conversion of an appropriate substrate
(e.g., hippuryl-His-Leu, HHL; furanocryloyl tri-peptide, FAPGG; or
aminobenzoylglycyl-p-nitrophenylalanylproline) by ACE is assayed
for. IC50 values obtained by distinct methods may, however, be not
fully consistent with each other (Murray, Walsh, & FitzGerald,
2004), but the differences found are minor in degree e and
certainly not of order of magnitude, so comparison along these
lines was pursued (Li et al., 2005; Vermeirssen, van Camp, &
Verstraete, 2002).
Realization that the molecular mass of most ACE-inhibitory
peptides is below 3 kDa prompted use of ultrafiltration, with
a cut-off of 3 kDa, of the whey protein hydrolysates; the peptides in
the permeate showed much lower IC50 values, as expected; and
even in the case of CMP hydrolysates e which were essentially
deprived of inhibition capacity, the corresponding <3 kDa fraction
proved slightly active. The most abundant protein in whey (b-Lg) is
not significantly broken down by cardosins (Barros & Malcata,
2006), and CMP peptide fractions do not possess a significant
ACE-inhibitory activity; hence, comparing the IC50 values of the
<3 kDa fractions of WPC and of a-La, one may readily hypothesize
that most active peptides found in WPC hydrolysates are actually
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Fig. 1. Standardized Pareto charts encompassing the effect of each term in the model (i.e., t
interaction thereof (linear)), divided by its standard error, pertaining to three responses (i.e
inhibitory activity), obtained fromwhey protein concentrate (WPC), a-lactalbumin (a-La) and
vertical line in each chart represents the 10% significance level; dark bars represent a positThe statistical significance of the various terms in the poly-
nomial model, fitted by multiple linear regression to the data, are
apparent in Fig. 1, pertaining to the three substrates and the three
responses; these Pareto charts emphasize the relevance of
including each such term in the final model. The vertical line in
the chart accounts for significance of the effects for a 90% confi-
dence level; and the effects, either positive (þ) or negative (), in
the response variables are indicated by different bar shadings. For
simplicity of analysis, the effects were sorted by decreasing
absolute value. Both hydrolysis time (T) and E/S ratio (R) were
significantly different from zero for all response variables; T and R
exhibited the strongest influence in terms of DH of WPC and CMP
(P< 0.05), and of a-La (P< 0.01); R was highest in terms of anti-
oxidant activity upon a-La and CMP (P< 0.05); T and R were
strongest in terms of ACE-inhibitory activity of the total WPC
(P< 0.05) and a-La (P< 0.01); R was highest in terms of ACE-
inhibitory activity of the <3 kDa fraction of WPC, a-La and CMP
(P< 0.05); and T was highest in terms of ACE-inhibitory activity of
the <3 kDa fraction upon WPC (P< 0.05). Higher order terms (i.e.,
T2, R2 and TR) played a lesser role, except in the following cases:
T2 in terms of ACE-inhibitory activity of total and <3 kDa fractions
of a-La (P< 0.01 and P< 0.1 respectively), and in terms of anti-
oxidant activity of WPC (P< 0.1); R2 in terms of DH of a-La
(P< 0.05); and TR in terms of ACE-inhibitory activity of total and
<3 kDa fraction of a-La (P< 0.05 and P< 0.1, respectively), and of
the <3 kDa fraction of WPC (P< 0.05). As expected (and also
apparent in Fig. 1), those factors influenced DH according to
a similar pattern: the response increased when either T or R
increased.ACE-INHIBITORY   ACTIVITY
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ime, T (linear and quadratic), enzyme/substrate (E/S) ratio, R (linear and quadratic) and
., degree of hydrolysis, antioxidant activity and angiotensin-converting enzyme (ACE)-
caseinomacropeptide (CMP), hydrolysed with Cynara cardunculus aqueous extract. The
ive effect, grey bars represent a negative effect.
The terms of the polynomial model not significantly different
from zero (P> 0.10) were excluded from its reformulated version,
which was re-fitted to the data, once again by multiple linear
regression; the results are listed in Table 2, including a number of
relevant statistics. Upon inspection of this table, one concludes
that: (i) the determination coefficient (R2) was higher than 0.90 for
ACE-inhibitory activity power (except in the case of CMP), but only
higher than 0.73 for DH and higher than 0.53 for antioxidant
capacity; hence, the model was found to be statistically appropriate
to describe the ACE-inhibitory activity results associated with
hydrolysis of WPC and a-La, besides the DH of a-La; and (ii) the
relative standard deviation (RSD), using the mean value of each
response as reference that provides a measure of the relative error
of the fit, was always below 20% (except for the ACE-inhibitory
activity response of a-La, which was slightly higher).
The response surfaces pertaining to DH of a-La, as well as to
ACE-inhibitory activity of WPC and a-La are shown in Fig. 2, as
a function of reaction time and E/S ratio. The maximum DH occurs
at as high as possible T and R, so the optimum lies on physical
constraints, i.e., 7 h and 11.5% (v/v), respectively.
The optimum processing conditions and the corresponding
prediction by the model for the ACE-inhibitory activity of WPC and
a-La hydrolysates are depicted in Table 3. The best reaction time
was again the longest allowed (i.e., 7 h), whereas the optimum E/S
ratio was 1.6 for three of the four responses considered. Note that
the effect of R is, in general, more important than that of T upon
the final response (see Table 3 and Fig. 1). Based on these optimum
values, one concludes that different substrates, having been
exposed to similar reaction conditions, lead to identical activity in
the case of <3 kDa fraction from WPC and a-La; once again, these
pieces of evidence support the claim that the peptides accounting
for ACE-inhibitory activity in whey hydrolysates are contributed
by a-La.
3.2. ACE-inhibitory activity and antioxidant activity
The optimum loci for WPC and a-La were: 1.6% (v/v) crude
aqueous extract, with a protein concentration of 40 g L1, in contact
with said substrate proteins for 7 h at 55 C and pH 5.2. The
resulting hydrolysates were characterized by DH values of 18 andTable 2
Best estimates of each term in the model, time, T (linear and quadratic), enzyme/substr
sponding statistics (R2, RSD and RRSD), pertaining to three responses (degree of hydrolysis
both total hydrolysate and its fraction below 3 kDa), obtained from the three substrates, w
Cynara cardunculus aqueous extract.a
Term Substratesb












Constant 1.208 0.3250 264.1 124.0 2.104 0.41
T 1.485z 0.2323 11.90z 16.75z 0.1181z 0.03
R 0.7547b 0.005600 23.38z 9.589z 0.9387z 0.03
T T 0.03270y 0.1020*
T R 1.723z
R R 1.249* 0.1133z
Statisticc
R2 0.731 0.597 0.928 0.925 0.971 0.54
RSD 2.95 0.160 13.9 7.29 0.650 0.15
RRSD 26.1 26.8 10.5 18.2 15.9 19.7
a Regression coefficients significantly different from zero are indicated by: *P< 0.1; yP
b Degree of hydrolysis obtained by TNBS (picrylsulfonic acid solution) method (%); an
(mmol trolox equivalent per mg hydrolysed protein); ACE-inhibitory activity obtained ac
(IC50, mgmL1).
c R2, coefficient of determination; RSD, residual standard deviation; RRSD, residual sta9%, for WPC and a-La, respectively; and by ACE-inhibitory activities
of 105.4 (total fraction) and 25.6 mgmL1 (<3 kDa fraction) for
WPC, and 47.6 (total fraction) and 22.5 mgmL1 (<3 kDa fraction)
for a-La. The actual experimental optima lay within the 95%
confidence interval (CI) of the values theoretically estimated as
optima via the model (Table 3), so the model proved adequate to
describe our data.
The features of our hydrolysates were compared with those of
others derived from CN, whey protein and milk, and claimed to
bear similar bioactivities. The classical approach to obtain ACE-
inhibitory hydrolysates is via enzymatic hydrolysis (e.g., using
pepsin, trypsin, thermolysin or proteases from lactic acid
bacteria); Tsai, Chen, Pan, Gong, and Chung (2008) even claimed
that when milk is fermented by a protease further to lactic acid
bacteria, more active peptides will be produced that inhibit ACE
activity, e.g., an IC50 value of 226 mgmL1 was obtained for
hydrolysates of individual whey proteins produced with Fla-
vourzyme and pepsin, instead of above 1000 mgmL1 (Pihlanto-
Leppälä, Koskinen, Piilola, Tupasela, & Korhonen, 2000); the IC50
results obtained in our study were even lower, especially noting
that the same substrate was used.
Furthermore, peptic hydrolysates of ovine and bovine CN were
found to contain potent inhibitors of ACE activity, with IC50 values
in the range 10e53 mgmL1 (López-Expósito et al., 2007; Miguel,
Contreras, Recio, & Aleixandre, 2009); caseinate and CN hydro-
lysed by trypsin or an extracellular protease of Lactobacillus helve-
ticus presented IC50 values below 30 mmol L1 (Robert, Razaname,
Mutter, & Juillerat, 2004; Tauzin, Miclo, & Gaillard, 2002); and
Ortiz-Chao et al. (2009) surprisingly produced hydrolysates of b-Lg
with a food-grade commercial proteolytic preparation, for an IC50
value of 100 mgmL1. Muguerza et al. (2006) assayed milk samples,
fermented by 231 different microorganisms previously isolated
from raw cows’milk, for their ACE-inhibitory activity; among them,
four Enterococcus faecalis strains stood out that led to IC50 of
34e59 mgmL1. Otte et al. (2007) found the highest ACE-inhibitory
activity in thermolysin-mediated hydrolysates of CN and whey
proteins, viz. 90e400 and 45e83 mgmL1, respectively (with a-La
specifically producing the highest inhibitory activity), followed by
protease K, trypsin, pepsin and Bacillus licheniformis protease; these
results encompass the range observed in our study, either for WPCate (E/S) ratio, R (linear and quadratic) and interaction thereof (linear), and corre-
, antioxidant activity and angiotensin-converting enzyme (ACE)-inhibitory activity of












Total <3 kDa <3 kDa
83 517.8 54.34 1.092 0.07530 513.0
050 102.7z 0.6022 0.5893y 0.0004000 12.21
830y 34.61z 3.322y 0.5153z 0.009000y 21.16y
4.469y 0.8085*
5.371y 0.6000y
2 0.973 0.903 0.790 0.532 0.569
0 24.2 3.51 1.28 0.0300 78.9
21.7 10.1 29.7 23.4 26.7
< 0.05; zP< 0.01.
tioxidant activity obtained by ORAC (Oxygen Radical Absorbance Capacity) method
cording to Sentandreu and Toldrá (2006), after modification by Quirós et al. (2009)
ndard deviation, expressed as percent of mean value of response.
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Fig. 2. Variation of two predicted responses (degree of hydrolysis and angiotensin-converting enzyme (ACE)-inhibitory activity), as a function of each term in the model (time, T,
and enzyme/substrate (E/S) ratio, R), obtained from whey protein concentrate (WPC) and a-lactalbumin (a-La), hydrolysed with Cynara cardunculus aqueous extract.or individual whey protein (a-La) digestion. However, almost all
such results were obtained with whole milk or CN, and not with
isolated whey protein or WPC.
From a comparison of our hydrolysates with others available
commercially, viz., BIPRO (Danisco), obtained by ion exchange
chromatography from a standard WPI (94%, w/w, protein), and
a b-Lg-enriched WPI, one realizes that the former hydrolysate
exhibited a lower IC50, i.e., 290e450 mgmL1, than the b-Lg-
enriched counterpart, i.e., 530e900 mgmL1 (Davis et al., 2001);
hence, the performance of the commercial competitors was actu-
ally much worse. Other patented products, viz., DMV (Arla and
Danisco), a WPI hydrolysate (Schlothauer et al., 2002) and a WPC
trypsin hydrolysate (Davis et al., 2001), exhibited IC50 values of
30e40, 25.4 and 62 mgmL1, respectively; these are similar to those
obtained here for the total and the fraction below 3 kDa ofWPC andTable 3
Maximum angiotensin-converting enzyme (ACE)-inhibitory activity of total hydro-
lysate and of its fraction below 3 kDa, and corresponding values of two processing
parameters, time and enzyme/substrate (E/S) ratio, obtained from two substrates,
whey protein concentrate (WPC) and a-lactalbumin (a-La), hydrolysed with Cynara
cardunculus aqueous extract.
Substrate Fraction Optimum processing conditions Predicted
responsea
Time (h) E/S ratio (%, v/v)
WPC Total 7.0 9.4 71.02 23.93
<3 kDa 7.0 1.6 10.06 24.22
a-La Total 7.0 1.6 21.40 84.40
<3 kDa 7.0 1.6 19.95 12.76
a Values are expressed as mean standard deviation (n¼ 2).a-La. The aforementioned low IC50 values appear, nevertheless, to
be an exception in the portfolio of commercial milk protein
hydrolysates.
Finally, the antioxidant activity of hydrolysates produced from
WPC and a-La, under the best processing conditions, was a mere
0.96 0.08 and 1.12 0.13 mmol trolox equivalent permg hydrolysed
protein, respectively; since none of such hydrolysates exhibited
a relevant antioxidant activity, no further tests were pursued.
3.3. Identification of potentially bioactive peptides
The peptides present in each hydrolysate were characterized by
liquid chromatographyetandem mass spectrometry (LCeMS/MS)
and the major results thus obtained are presented in Table 4. As
expected, most peptides in theWPC hydrolyzate derived from a-La.
In terms of specificity of the plant proteases used, the substrate
cleavage sites were all next to hydrophobic amino acid residues,
especially Phe, Leu, Thr and Tyr. In the case of a-La these were:
Phe9-Arg10, Leu15-Lys16, Trp26-Val27, Phe31-His32, Tyr36-Asp37,
Ala40-Ile41, Leu52-Phe53, Phe80-Leu81, Ile89-Met90, Leu96-
Asp97, Asp97-Lys98, Tyr103-Trp104, Trp104-Leu105 and Leu105-
Ala106. In other cases these were: for CMP, Phe105-Met106,
Met106-Ala107, Asp115-Lys116, Asn123-Thr124 and Asn160-
Thr161; for b-CN, Leu6-Asn7, Met93-Gly94 and Lys105-His106;
and for b-Lg, Leu32-Asp33 and Tyr42-Val43. Those results are
essentially consistent with reports by Barros andMalcata (2006) on
pure cardosins.
Several authors have attempted to relate the primary structure
of peptides to their ACE-inhibitory activity; it appears consensual
that hydrophobic amino acids at the three consecutive C-terminal
positions are particularly favourable (Li, Le, Shi, & Shrestha, 2004;
Table 4
Identification of peptides in the fraction below 3 kDa obtained from two substrates,
















a-La f32e40 HTSGYDTQA a-La f32e40 HTSGYDTQA
CMP f107e115 AIPPKKNQD a-La f10e15 RELKDL
CMP f106e115 MAIPPKKNQD a-La f97e103 DKVGINY
b-CN f94e105 GVSKVKEAMAPK a-La f81e89 LDDDLTDDI
CMP f161e169 TVQVTSTAV a-La f41e52 IVQNNDSTEYGL
a-La f10e15 RELKDL a-La f37e52 DTQAIVQNNDSTEYGL
a-La f97e103 DKVGINY a-La f97e104 DKVGINYW
CMP f116e123 KTEIPIN a-La f16e26 KGYGGVSLPEW




a-La f16e26 KGYGGVSLPEWLópez-Fandiño et al., 2006; Pripp, Sørensen, Stepaniak, & Sørhaug,
2006). Cheung, Wang, Ondetti, Sabo, and Cushman (1980)
claimed that Pro, Trp, Tyr and Phe specifically are the most effec-
tive C-terminal amino acid residues, as happenedwith our peptides
DKVGINY (f97e103), KVGINYW (f98e104), DKVGINYW (f97e104)
and KGYGGVSLPEW (f16e26) from a-La, as well as DAQSAPLRVY
(f33e42) from b-Lg. The presence of Pro at the final and at the
second position before the final in the C-terminus (Stevens,
Micalizzi, Fessler, & Pals, 1972) apparently favours affinity to ACE;
the same holds for Leu as the final C-terminal amino acid residue
(Gómez-Ruiz, Ramos, & Recio, 2004; Kim, Byun, Park, & Fereidoon,
2001), as is the case of our RELEEL (f1e6) from b-CN and RELKDL
(f10e15) from a-La. This is consistent with results of quantitative
structureeactivity studies.
Conversely, no relationship has to date been claimed between
the N-terminal structure and the ACE-inhibitory activity (Pripp,
Isaksson, Stepaniak, & Sørhaug, 2004). Three peptides similar to
those identified in our WPC hydrolysates have been described
before to also bear ACE-inhibitory activity: fragments f15e26 and
f21e26, in a thermolysin-mediated hydrolysate of bovine a-La (Otte
et al., 2007); and f33e42, in an Amano Protease N-mediated
hydrolysate of bovine b-Lg (Ortiz-Chao et al., 2009).
The peptides MAIPPKKNQD (f106e115) and AIPPKKNQD
(f107e115) released from CMP (see Table 4), both of which have
a dicarboxylic amino acid at their C-termini, should not in principle
promote any relevant ACE-inhibitory activity; however, they can be
precursors of bioactive peptides because they comprise the
isoleucine-proline-proline (IPP) sequence that has been associated
with very potent ACE-inhibition, e.g., an IC50 of only 5 mM
(Nakamura, Masuda, & Tanako, 1996).
Finally, two active anti-thrombotic peptides have been reported,
following hydrolysis of ovine CMP by a trypsin preparation con-
taining traces of chymotrypsin: TAQVTSTEV (f163e171) and
QVTSTEV (f165e171) (Qian, Jollès, Migliore-Samour, Schoentgen, &
Fiat, 1995). A peptide with an equivalent sequence was present in
a hydrolysed bovine CMP counterpart, corresponding to the
sequence TVQVTSTAV (f161e169) (Manso, Escudero, Alijo, & López-
Fandiño, 2002), which was also found in our study.4. Conclusions
The degree of hydrolysis of bovine WPC and a-La was maximal
when 1.6% (v/v) commercial crude extract of C. cardunculuswas leftto act for 7 h, at 55 C and pH 5.2. The resulting hydrolysates,
characterized by DH of 18 and 9%, for WPC and a-La, respectively,
exhibited ACE-inhibitory activities characterized by an IC50 of 105.4
(total fraction) and 25.6 mgmL1 (<3 kDa fraction) in the case of
WPC, and 47.6 (total fraction) and 22.5 mgmL1 (<3 kDa fraction) in
the case of a-La; these figures can be considered as high when
compared with the typical IC50 of dairy protein hydrolysates
described in the literature. However, their antioxidant activities
attained a mere 0.96 and 1.12 mmol trolox equivalent per mg hy-
drolysed protein, for WPC and a-La, respectively.
Of special interest were the novel fragments generated from
a-La, viz., DKVGINY (f97e103), KVGINYW (f98e104), DKVGINYW
(f97e104) and KGYGGVSLPEW (f16e26), as well as DAQSAPLRVY
(f33e42) from b-Lg, owing to their particularly low values of
IC50; note that all of them possess hydrophobic residues at the
C-terminus. Furthermore, the CMP-derived peptide TVQVTSTAV
(f161e169) was analogous to a peptide claimed elsewhere to
possess anti-thrombotic activity. Further work using animalmodels
is now required to determine whether our promising peptides can
also exert antihypertensive activity in vivo.
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